In-Depth Insight
Prognosis Calculators
Enhance your professional approach to Myelodysplastic Syndromes with our specialized IPSS-R and IPSS-M calculators. Designed for healthcare professionals, these tools provide in-depth prognostic insights to inform strategic decision-making in MDS care.
IPSS-M Calculator
IPSS-M Calculator
The IPSS-M is the newest MDS prognosis calculator that combines genomic profiling with hematologic and cytogenetic parameters, improving the risk stratification of patients with MDS. This is a valuable tool for clinical decision-making, offering the prospect of tailoring diagnosis and therapeutic interventions to each patient’s molecular profile.
iPhone App
Android App
IPSS-R Calculator
IPSS-R Calculator
The IPSS-R App is an advanced tool designed to enhance the prognosis assessment for patients with myelodysplastic syndromes (MDS). Building on the Revised International Prognostic Scoring System (IPSS-R), the app integrates a vast array of clinical data and predictive features to deliver a precise categorization model. By evaluating key factors such as bone marrow cytogenetics, marrow blast percentage, and depth of cytopenias, alongside patient age, performance status, and serum biomarkers, the app provides a comprehensive risk assessment. This innovative tool aids healthcare professionals in predicting clinical outcomes more accurately, facilitating better-informed decisions in the management and treatment of MDS patients.
*Data for the IPSS-R & IPSS-M calculators are derived from:
- Bernard E, Tuechler H, Greenberg PL, et al, The Molecular International Prognosis Scoring System (IPSS-M) for risk stratification in myelodysplastic syndromes. New Eng J Med Evidence. https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200008. Study supported by the MDS Foundation.
- Greenberg P, Tuechler H, Schanz J, et al, Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes. Blood 120: 2454-2465, 2012.
